Key Insights

Highlights

Success Rate

75% trial completion

Treatment Research

11 treatments under study, led by Education

Research Leaders

7 sponsors active, led by Oregon Health and Science University

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

20.0%

1 terminated out of 5 trials

Success Rate

75.0%

-11.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results75% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
Phase 1 (1)

Trial Status

Completed3
Terminated1
Recruiting1

Trial Success Rate

75.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Education1
  • Topical Hormonal Cream Estrogen1
  • Virtual Online Pelvic Health Program1
  • Nonclassical Acupuncture1
  • Educational Seminars1

Active Sponsors

  • Oregon Health and Science University3
  • Queen's University1
  • Meir Medical Center1
  • National Vulvodynia Association1
  • Oregon College of Oriental Medicine1

Top Investigators

Related Conditions

  • Vulvar Vestibulitis2
  • Provoked Vestibulodynia2
  • Vulvodynia Chronic Vulvar Pain1
  • Vestibulodynia1
  • Vulvodynia1

Activity Timeline